On April 9, Shijiazhuang Yiling Pharmaceutical Co., Ltd donated 2 million yuan to the Red Cross foundation of China to be used in the international humanitarian assistance fund to support the prevention and control of the international epidemic. After the outbreak of the new epidemic, Yiling Pharmaceutical took the lead in donating Lianhua Qingwen capsules which worth more than 10 million yuan to support the prevention and control of the domestic epidemic. After the situation of overseas epidemic prevention and control intensified, Yiling Pharmaceutical actively supported the international epidemic prevention and control. On March 12, 2016, it donated 1.8944 million yuan and 1.48 million Lianhua Qingwen capsules to the Red Cross society of China to support the epidemic prevention and control in Iraq and Italy.

Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., introduced that the company's patented traditional Chinese medicine, Lianhua Qingwen capsules (granules), has been recommended by the national and more than 20 provinces and cities for the treatment of covid-19. It has become the most frequently recommended Chinese patent medicine and is widely used in medical institutions.

Cao Xuejun, deputy director of the consumer goods industry department of the ministry of industry and information technology, said that drugs are the important material basis and the guarantee for the prevention and control of the epidemic at a press conference on April 8.

After the relevant drugs were included in the medical plan, the enterprise has been producing at full capacity, with sufficient inventory and guaranteed market supply. Up to now, the daily production capacity of Lianhua Qingwen capsules has reached 2 million boxes and the inventory is 30 million boxes.

In the battle against epidemic diseases, traditional Chinese medicine has been rarely seen in its wide participation, deep participation and high attention. The role of traditional Chinese medicine is fully reflected in the whole process of prevention, treatment and rehabilitation.

Before this, Lianhua Qingwen has been already exported to Canada, Romania, Thailand, Mozambique, Brazil, Indonesia and China Hong Kong, Macao. Since the end of February, the company has received orders from overseas, and the demand for drugs has been rising rapidly. Chinese traditional medicine began to go abroad and was recognized by the international community.